PURPOSE OF REVIEW: Myeloid dendritic cells (mDCs) are pivotal players in HIV-1 infection. They promote transmission and spread and at the same time are critical for recognizing HIV-1 and initiating immune responses to fight infection. Notably, their immunostimulatory capabilities can be harnessed to design better HIV-1 vaccines. In this review, advances in these areas of mDC-HIV-1 interactions are summarized. RECENT FINDINGS: New insights into HIV-1-induced dysfunction of mDCs and dysfunctional mDC effects on other cell types, as well as novel mechanisms of viral sensing by mDCs and their evasion by HIV-1, have been uncovered. These results emphasize the importance of mDCs in protection against HIV-1 infection. Targeting mDCs with vaccines and tailored adjuvants may improve the quality and anatomical location of elicited immune responses. SUMMARY: Understanding the multiplicity of HIV-1-dendritic cell interactions together with the numerous advances in targeted therapy and vaccination will help in the rational design of approaches to treat and block infection.
PURPOSE OF REVIEW: Myeloid dendritic cells (mDCs) are pivotal players in HIV-1 infection. They promote transmission and spread and at the same time are critical for recognizing HIV-1 and initiating immune responses to fight infection. Notably, their immunostimulatory capabilities can be harnessed to design better HIV-1 vaccines. In this review, advances in these areas of mDC-HIV-1 interactions are summarized. RECENT FINDINGS: New insights into HIV-1-induced dysfunction of mDCs and dysfunctionalmDC effects on other cell types, as well as novel mechanisms of viral sensing by mDCs and their evasion by HIV-1, have been uncovered. These results emphasize the importance of mDCs in protection against HIV-1 infection. Targeting mDCs with vaccines and tailored adjuvants may improve the quality and anatomical location of elicited immune responses. SUMMARY: Understanding the multiplicity of HIV-1-dendritic cell interactions together with the numerous advances in targeted therapy and vaccination will help in the rational design of approaches to treat and block infection.
Authors: Yongjun Sui; Qing Zhu; Susan Gagnon; Amiran Dzutsev; Masaki Terabe; Monica Vaccari; David Venzon; Dennis Klinman; Warren Strober; Brian Kelsall; Genoveffa Franchini; Igor M Belyakov; Jay A Berzofsky Journal: Proc Natl Acad Sci U S A Date: 2010-05-10 Impact factor: 11.205
Authors: Godwin Nchinda; David Amadu; Christine Trumpfheller; Olga Mizenina; Klaus Uberla; Ralph M Steinman Journal: Proc Natl Acad Sci U S A Date: 2010-02-16 Impact factor: 11.205
Authors: Beth K Thielen; John P McNevin; M Juliana McElrath; Brook Vander Stoep Hunt; Kevin C Klein; Jaisri R Lingappa Journal: J Biol Chem Date: 2010-07-08 Impact factor: 5.157
Authors: Patricia R Taylor; Christopher C Paustian; Gary K Koski; Daniel H Zimmerman; Ken S Rosenthal Journal: Cell Immunol Date: 2010-02-01 Impact factor: 4.868
Authors: Rita Cavaleiro; António P Baptista; Russell B Foxall; Rui M M Victorino; Ana E Sousa Journal: AIDS Res Hum Retroviruses Date: 2009-04 Impact factor: 2.205
Authors: Elena Martinelli; Hugo Tharinger; Ines Frank; James Arthos; Michael Piatak; Jeffrey D Lifson; James Blanchard; Agegnehu Gettie; Melissa Robbiani Journal: PLoS Pathog Date: 2011-06-30 Impact factor: 6.823
Authors: Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey Journal: Nat Med Date: 2009-08-02 Impact factor: 53.440
Authors: Viskam Wijewardana; Anthea L Bouwer; Kevin N Brown; Xiangdong Liu; Simon M Barratt-Boyes Journal: Immunology Date: 2014-10 Impact factor: 7.397
Authors: Stephanie C Gordts; Geoffrey Férir; Thomas D'huys; Mariya I Petrova; Sarah Lebeer; Robert Snoeck; Graciela Andrei; Dominique Schols Journal: PLoS One Date: 2015-07-01 Impact factor: 3.240
Authors: Viskam Wijewardana; Jan Kristoff; Cuiling Xu; Dongzhu Ma; George Haret-Richter; Jennifer L Stock; Benjamin B Policicchio; Adam D Mobley; Rebecca Nusbaum; Hadega Aamer; Anita Trichel; Ruy M Ribeiro; Cristian Apetrei; Ivona Pandrea Journal: PLoS Pathog Date: 2013-10-03 Impact factor: 6.823